Shuttle Pharmaceuticals Holdings, Inc.
$0.59-2.58%($-0.02)
TickerSpark Score
51/100
90
Valuation
20
Profitability
60
Growth
56
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SHPH research report →
52-Week Range2% of range
Low $0.50
Current $0.59
High $6.20
Companywww.shuttlepharma.com
Shuttle Pharmaceuticals Holdings, Inc. , through its subsidiary, Shuttle Pharmaceuticals, Inc. , focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy.
- CEO
- Christopher Robert Cooper
- IPO
- 2022
- Employees
- 9
- HQ
- Gaithersburg, MD, US
Price Chart
-88.16% · this period
Valuation
- Market Cap
- $635.29K
- P/E
- -0.28
- P/S
- 0.00
- P/B
- 0.89
- EV/EBITDA
- 0.02
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -408.33%
- ROIC
- -312.04%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-11,721,669 · -28.18%
- EPS
- $-7.16 · 99.19%
- Op Income
- $-11,916,824
- FCF YoY
- -29.40%
Performance & Tape
- 52W High
- $6.20
- 52W Low
- $0.50
- 50D MA
- $0.83
- 200D MA
- $2.11
- Beta
- 1.41
- Avg Volume
- 907.48K
Get TickerSpark's AI analysis on SHPH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 6, 26 | Liang Yuying | other | 0 |
| Sep 12, 25 | Liriano Angel | other | 0 |
| Sep 12, 25 | Pathigoda Arachchige Sachin Eranga | other | 0 |
| Sep 8, 25 | Chambers Adam V | other | 0 |
| Aug 8, 25 | Richards Steven M | other | 29,240 |
| Aug 8, 25 | Nabyt Oleh | other | 29,240 |
| Aug 8, 25 | Scorsis George | other | 29,240 |
| Aug 8, 25 | Tung Joseph | other | 29,240 |
| Aug 8, 25 | Lorber Timothy J. | other | 29,240 |
| Aug 8, 25 | Lorber Timothy J. | other | 24,854 |
Our SHPH Coverage
We haven't published any research on SHPH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SHPH Report →